Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Evaluation of the Mean Duration of Recent Infection (MDRI) and the False Recent Rate (FRR) for the Limiting Antigen Avidity Enzyme Immune Assay (LAg) and Bio-Rad HIV ½ Plus O Avidity Incidence Assay (BRAI)

Thesis (PhD)--Stellenbosch University, 2017.

Saved in:
Bibliographic Details
Main Author: Gonese, Elizabeth
Other Authors: Hargrove, John
Format: Thesis
Language:en_ZA
Published: Stellenbosch : Stellenbosch University 2017
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867613896932589568
access_status_str Open Access
author Gonese, Elizabeth
author2 Hargrove, John
author_browse Gonese, Elizabeth
Hargrove, John
author_facet Hargrove, John
Gonese, Elizabeth
author_sort Gonese, Elizabeth
collection Thesis
dc_rights_str_mv Stellenbosch University
description Thesis (PhD)--Stellenbosch University, 2017.
format Thesis
id oai:scholar.sun.ac.za:10019.1/102902
institution Stellenbosch University (South Africa)
language en_ZA
last_indexed 2026-06-10T12:43:26.328Z
license_str Other — see source repository
provenance_str_mv Harvested via OAI-PMH from SUNScholar — Stellenbosch University Repository
publishDate 2017
publishDateRange 2017
publishDateSort 2017
publisher Stellenbosch : Stellenbosch University
publisherStr Stellenbosch : Stellenbosch University
record_format dspace
source_str SUNScholar — Stellenbosch University Repository
spelling oai:scholar.sun.ac.za:10019.1/102902 Evaluation of the Mean Duration of Recent Infection (MDRI) and the False Recent Rate (FRR) for the Limiting Antigen Avidity Enzyme Immune Assay (LAg) and Bio-Rad HIV ½ Plus O Avidity Incidence Assay (BRAI) Gonese, Elizabeth Hargrove, John Nachega, Jean Van Zyl, Gert Kilmarx, Peter H. Stellenbosch University. Faculty of Medicine and Health Sciences. Dept. of Global Health. Epidemiology and Biostatistics. HIV infection -- Epidemiology Mean Duration of Recent Infection (MDRI) False Recent Rate (FRR) Limiting Antigen Avidity Enzyme Immune Assay (LAg) Bio-Rad HIV ½ Plus O Avidity Incidence Assay (BRAI) HIV infections -- Testing UCTD Thesis (PhD)--Stellenbosch University, 2017. ENGLISH SUMMARY : Background: The evaluation of laboratory assays in estimating HIV incidence has become a priority because of the complexity of HIV epidemics and the need to measure the impact of public health interventions targeting reduction of HIV incidence. Biomarkers should have test properties that allow the lowest possible False Recent Rate (FRR, or probability of diagnosing a long-term infection as recently infected) over the longest possible period (Mean Duration of Recent Infection or MDRI) during which the case is considered as a recent infection. Methods: We compared the BED Capture Enzyme Immunoassay (BED), Sedia Limiting Antigen (LAg) and Bio-Rad HIV ½ Plus O Avidity Incidence Assay (BRAI) using samples from a prospective cohort trial, the Zimbabwe Vitamin A for Mothers and Babies Project (ZVITAMBO) 1997–2000. We determined MDRI using 591 samples from 184 seroconverting women, and determined FRR by testing 2825 cases known to be HIV- positive for >12 months. We used these results to estimate HIV incidence over the first 12 months postpartum, and during the period prior to childbirth. Results: At recommended cut-offs MDRI values were: BRAI, 135 days (120 – 151) at Avidity Index (AI) 30%; LAg, 104 days (98 - 110) at ODn cut-off 1.5; BED, 188 days (180 -196) at ODn cut-off 0.8. All error bounds in this thesis signify 95% confidence intervals. The coefficients of variation (CV) of the MDRI estimates for BRAI, LAg and BED were 5.9%, 2.9% and 2.1%, respectively. Corresponding FRRs were 1.1% (0.7-1.5) for BRAI, 0.6% (0.3-0.9) for LAg and 4.8% (4.1-5.7) for BED. MDRI and FRR estimates, all derived using postpartum women, were lower than in other published studies. Using original ZVITAMBO HIV diagnoses, adjusted HIV incidence over the first 12 months postpartum was estimated as; BRAI, 2.7% (1.8-3.7); LAg, 3.7% (2.7-4.8); BED, 3.6% (2.4 -4.9). Follow-up incidence was 3.4% (3.0-3.8). When cases with viral load <1000 copies/ml were defined as long-term infections, regardless of serological biomarker level, FRRs were; BRAI, 1.0% (0.7-1.5); LAg, 0.2% (0.2 -0.7); BED 3.8% (3.1-4.6). MDRIs were; BRAI, 133 days (113-154); LAg, 101 days (87-115); BED, 177 days (155 - 199). Corresponding incidences, unadjusted for FRR, were: BRAI, 3.9% (2.9-4.9); LAg, 3.1% (2.1-4.0); BED, 6.2 % (5.0-7.3). Adjusted estimates were 2.7% (1.5-4.0), 2.5% (1.6-3.5) and 2.6% (1.6-3.7) respectively. At baseline, with no follow-up estimate for comparison, adjusted incidence for serological biomarkers used alone were; BRAI, 8.1% (6.6-9.7); LAg, 6.9% (5.7-8.1); BED 6.7% (5.5-7.9). When viral load was also used, the adjusted and unadjusted incidence estimates were; BRAI, 7.3% (5.7-8.8) and 8.4% (6.8-10.0); LAg, 5.1% (3.9-6.3) and 5.7% (4.5-6.9); BED, 5.4% (4.1-6.7) and 8.6% (7.3-10.0). Conclusion: At recommended cut-offs; BRAI FRR was 1.9 times higher than that of LAg. BRAI MDRIs were also 1.3 times higher, but with a relative standard error 2.4 times as high. Postpartum BRAI incidence estimates were consistently lower than follow-up estimates. Adjusted biomarker estimates under-estimated follow-up incidence when we used viral load in combination with either serological test. AFRIKAANSE OPSOMMING : Geen opsomming beskikbaar. 2017-11-24T13:40:28Z 2017-12-11T11:10:05Z 2017-11-24T13:40:28Z 2017-12-11T11:10:05Z 2017-12 Thesis http://hdl.handle.net/10019.1/102902 en_ZA Stellenbosch University xv, 165 pages ; illustrations application/pdf Stellenbosch : Stellenbosch University
spellingShingle HIV infection -- Epidemiology
Mean Duration of Recent Infection (MDRI)
False Recent Rate (FRR)
Limiting Antigen Avidity Enzyme Immune Assay (LAg)
Bio-Rad HIV ½ Plus O Avidity Incidence Assay (BRAI)
HIV infections -- Testing
UCTD
Gonese, Elizabeth
Evaluation of the Mean Duration of Recent Infection (MDRI) and the False Recent Rate (FRR) for the Limiting Antigen Avidity Enzyme Immune Assay (LAg) and Bio-Rad HIV ½ Plus O Avidity Incidence Assay (BRAI)
title Evaluation of the Mean Duration of Recent Infection (MDRI) and the False Recent Rate (FRR) for the Limiting Antigen Avidity Enzyme Immune Assay (LAg) and Bio-Rad HIV ½ Plus O Avidity Incidence Assay (BRAI)
title_full Evaluation of the Mean Duration of Recent Infection (MDRI) and the False Recent Rate (FRR) for the Limiting Antigen Avidity Enzyme Immune Assay (LAg) and Bio-Rad HIV ½ Plus O Avidity Incidence Assay (BRAI)
title_fullStr Evaluation of the Mean Duration of Recent Infection (MDRI) and the False Recent Rate (FRR) for the Limiting Antigen Avidity Enzyme Immune Assay (LAg) and Bio-Rad HIV ½ Plus O Avidity Incidence Assay (BRAI)
title_full_unstemmed Evaluation of the Mean Duration of Recent Infection (MDRI) and the False Recent Rate (FRR) for the Limiting Antigen Avidity Enzyme Immune Assay (LAg) and Bio-Rad HIV ½ Plus O Avidity Incidence Assay (BRAI)
title_short Evaluation of the Mean Duration of Recent Infection (MDRI) and the False Recent Rate (FRR) for the Limiting Antigen Avidity Enzyme Immune Assay (LAg) and Bio-Rad HIV ½ Plus O Avidity Incidence Assay (BRAI)
title_sort evaluation of the mean duration of recent infection mdri and the false recent rate frr for the limiting antigen avidity enzyme immune assay lag and bio rad hiv 1 2 plus o avidity incidence assay brai
topic HIV infection -- Epidemiology
Mean Duration of Recent Infection (MDRI)
False Recent Rate (FRR)
Limiting Antigen Avidity Enzyme Immune Assay (LAg)
Bio-Rad HIV ½ Plus O Avidity Incidence Assay (BRAI)
HIV infections -- Testing
UCTD
url http://hdl.handle.net/10019.1/102902
work_keys_str_mv AT goneseelizabeth evaluationofthemeandurationofrecentinfectionmdriandthefalserecentratefrrforthelimitingantigenavidityenzymeimmuneassaylagandbioradhiv1⁄2plusoavidityincidenceassaybrai